Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic...

Area of Science:

• Immunology
• Neuroscience
• Microbiology

Background:

• Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
• Epstein-Barr virus (EBV) and Mycobacterium avium subsp. paratuberculosis (MAP) have been implicated in MS etiology.
• Molecular mimicry is a proposed mechanism for autoimmune diseases.

Purpose of the Study:

• To investigate the prevalence of antibodies against EBV, MAP, and myelin basic protein (MBP) in a Sardinian MS cohort.
• To explore the potential cross-reactivity between antibodies targeting these peptides.
• To assess the role of molecular mimicry in MS pathogenesis.

Main Methods:

• Sera from MS patients and healthy controls were tested for antibodies against specific peptides from EBNA1 (EBV), MAP, and MBP.
• A competitive immunoassay was employed to evaluate antibody cross-reactivity.
• Statistical analysis was used to compare antibody prevalence between groups.

Main Results:

• Antibodies against EBNA1400-413, MAP121-132, and MBP85-98 were significantly more prevalent in MS patients than in healthy controls.
• Antibodies recognizing EBNA1400-413 and MAP121-132 demonstrated cross-reactivity with MBP85-98.
• These findings suggest a potential molecular mimicry mechanism involving EBV, MAP, and self-antigens in MS.

Conclusions:

• The study supports the hypothesis that EBV and MAP infections may trigger autoimmunity in MS through molecular mimicry.
• Cross-reactivity of antibodies against microbial peptides with self-epitopes like MBP is a key finding.
• These results highlight potential infectious triggers and autoimmune mechanisms in multiple sclerosis.